Your Health,
Our Happiness
Emergency Helpline
Agartala: 8974050300
- |
Dumdum: 033-40315001
- |
Howrah: 033-40880000
- |
Salt Lake: 033-40206500
INVESTOR RELATIONS
| Sl No. | Name of Director | Designation |
|---|---|---|
| 1 | Mr. Dwarika Prasad Tantia | Executive Chairman |
| 2 | Dr. Om Tantia | Managing Director |
| 3 | Dr. Aruna Tantia | Non-Executive Director |
| 4 | Dr. Ghanshyam Goyal | Non-Executive Director |
| 5 | Mr. Anurag Tantia | Executive Director |
| 6 | Mr. Bal Kishan Choudhury | Independent Director |
| 7 | Mr. Kashi Prasad Khandelwal | Independent Director |
| 8 | Mr. Saurabh Agarwal | Independent Director |
| 9 | Dr. Tapti Sen | Independent Director |
| 10 | Mr. Hari Modi | Independent Director |
| Policy Document | Download |
|---|---|
| Related Party Transaction Policy |  |
| Code for Conduct for Prevention of Insider Trading | |
| Code of Corporate Disclosure for PIT | |
| Famiarization Program For Independent Directors | |
| Performance Evaluation Policy | |
| Policy for Determining Materiality of Disclosures | |
| Criteria for making payment to Non Executive Directors | |
| CSR Policy | |
| Dividend Policy | |
| Policy for Document Rention and Archiva | |
| Prevention of Sexual Harassment Policy | |
| Related Party Transaction Policy | |
| Code of Conduct of Non Executive Directors | |
| Material Subsidiary-Policy | |
| Materiality Policy | |
| Nomination and Remuneration Policy | |
| Risk Management Policy | |
| Terms of Appointment of Independent Director | |
| Vigil Mechanism Policy | |
| Financial Year | Download |
|---|---|
| 2021-22 (Standalone & Consolidated) | |
| 2020-21 (Standalone & Consolidated) | |
| 2019-20 (Standalone & Consolidated) | |
| 2018-19 (Standalone & Consolidated) | |
| Sl. No. | Particulars | Download PDF |
|---|---|---|
| A1. | Offer Agreement | |
| A2. | Amendment to Offer Agreement | |
| A3. | Registrar Agreement | |
| A4. | Cash Escrow and Sponsor Bank Agreement | |
| A5. | Share Escrow Agreement | |
| A6. | Syndicate Agreement | |
| A7. | Underwriting Agreement | |
| A8. | Shareholder Agreement | |
| A9. | Non- Disposal Agreement | |
| A10. | Earmarking Agreement | |
| Sl. No. | Particulars | Download PDF | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B1. | Copy of MOA and AOA | | ||||||||||||||||||||||||||||||||
| B2. | Certificate of Incorporation | | ||||||||||||||||||||||||||||||||
| B3. | Board and Shareholder Resolution approving the Offer and other related matters | | ||||||||||||||||||||||||||||||||
| B4. | Board and IPO Committee Resolution approving the DRHP/RHP | | ||||||||||||||||||||||||||||||||
| B5. | Annual Reports
|
| ||||||||||||||||||||||||||||||||
| B6. | The examination report of the Statutory Auditor on our Restated Standalone Financial Information, included in this RHP | | ||||||||||||||||||||||||||||||||
| B7. | The examination report of the Statutory Auditor on our Restated Consolidated Financial Information, included in this RHP | | ||||||||||||||||||||||||||||||||
| B8. | Statement of special tax benefits | | ||||||||||||||||||||||||||||||||
| B9. | Certificate from Singhi & Co., Chartered Accountants in relation to the KPIs. | | ||||||||||||||||||||||||||||||||
| B10. | Written consent
|
| ||||||||||||||||||||||||||||||||
| B11. | Consent From CRISIL to reproduce report | | ||||||||||||||||||||||||||||||||
| B12. | Written consent from Singhi & Co., Chartered Accountants on various aspects | | ||||||||||||||||||||||||||||||||
| B13. | Written consent of independent chartered accountants | | ||||||||||||||||||||||||||||||||
| B14. | CRISIL Industry Report | | ||||||||||||||||||||||||||||||||
| B15. | Engagement Letter with CRISIL | | ||||||||||||||||||||||||||||||||
| B16. | Consent letters from the Selling Shareholders authorizing participation in the offer | | ||||||||||||||||||||||||||||||||
| B17. | Executive Directors' remuneration agreement and resolutions | | ||||||||||||||||||||||||||||||||
| B18. | Due diligence certificate | | ||||||||||||||||||||||||||||||||
| B19. | In–principle approvals | | ||||||||||||||||||||||||||||||||
| B20. | Tripartite agreement- NSDL | | ||||||||||||||||||||||||||||||||
| B21. | Tripartite agreement- CSDL | | ||||||||||||||||||||||||||||||||
| B22. | SEBI final observation letter | | ||||||||||||||||||||||||||||||||
| B23. | Board Resolution approving the RHP | | ||||||||||||||||||||||||||||||||
| B24. | SEBI exemption letter | | ||||||||||||||||||||||||||||||||
| B25. | Valid Peer Review Certificate | |
| Industry Report | Download PDF |
|---|---|
| Assessment of the healthcare delivery industry in India report | |
As per the Materiality Policy adopted by the Board of Directors of the Company the outstanding dues to the material creditors is NIL as on June 30, 2022.
AUDIT COMMITTEE
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Saurabh Agarwal | Chairman | Non-Executive - Independent Director |
| 2 | Mr. K. P. Khandelwal | Member | Non-Executive - Independent Director |
| 3 | Mr. Anurag Tantia | Member | Executive Director |
NOMINATION AND REMUNERATION COMMITTEE
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. K.P. Khandelwal | Chairman | Non-Executive Independent Director |
| 2 | Mr. Hari Modi | Member | Non-Executive Independent Director |
| 3 | Dr. Tapti Sen | Member | Non-Executive Independent Director |
CORPORATE SOCIAL RESPONSIBILITY COMMITTEE
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. D. P. Tantia | Chairman | Executive - Non Independent Director |
| 2 | Dr. Aruna Tantia | Member | Non-Executive - Non Independent Director |
| 3 | Dr. Tapti Sen | Member | Non-Executive - Independent Director |
STAKEHOLDERS RELATIONSHIP COMMITTEE
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Hari Modi | Chairman | Non-Executive Independent Director |
| 2 | Dr. Ghanshyam Goyal | Member | Non-Executive Non Independent Director |
| 3 | Mr. Anurag Tantia | Member | Executive Director |
RISK MANAGEMENT COMMITTEE
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. B. K. Choudhury | Chairman | Non-Executive - Independent Director |
| 2 | Mr. Saurabh Agarwal | Member | Non-Executive - Independent Director |
| 3 | Mr. Anurag Tantia | Member | Executive Director |
| 4 | Mrs. Kriti Tantia | Permanent Invitee | CFO |
EXECUTIVE COMMITTEE
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. D. P. Tantia | Chairman | Executive Non Independent Director |
| 2 | Dr. Om Tantia | Member | Executive Managing Director |
| 3 | Mr. Anurag Tantia | Member | Executive Director |
IPO COMMITTEE
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. D. P. Tantia | Chairman | Executive - Non Independent Director |
| 2 | Mr. Anurag Tantia | Member | Executive Director |
| 3 | Mr. Kashi Prasad Khandelwal | Member | Non-Executive - Independent Director |
INVESTOR HELPDESK:
Company Secretary and Compliance Officer
GPT Healthcare Limited
(Formerly GPT Healthcare Private Limited)
Mr. Ankur Sharma
GPT Centre, JC-25, Sector-III
Salt Lake, Kolkata - 700 106
Tel: +91 33 4050 7000
West Bengal, India
E-mail: ghl.cosec@gptgroup.co.in
Registrar & Share Transfer Agent
KOLKATA
Link Intime India Pvt. Ltd.
Room Nos.: 502 & 503, 5th floor, Vaishno Chamber
6, Brabourne Road, Kolkata - 700 001
Tel: +91 33 4004 9728 / 033 4073 1698
E-mail: kolkata@linkintime.co.in
MUMBAI
Link Intime India Pvt. Ltd.
C-101, 247 Park,
LBS MARG, Vikhroli (West)
Mumbai - 400083
Tel: +91 22 49186200
E-mail: gpthealthcare.ipo@linkintime.co.in
The name of the Company has been changed form "GPT Healthcare Private Limited" to "GPT Healthcare Limited" with effect from 15th September, 2021 vide fresh Certificate of Incorporation issued by Registrar of Companies, West Bengal.
| Name of the Company | Download |
|---|---|
| GPT Estate Private Limited | |
| GPT Castings Limited | |
| TM Medicare Private Limited | |